{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:10:16Z","timestamp":1782778216270,"version":"3.54.5"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1990,10,1]],"date-time":"1990-10-01T00:00:00Z","timestamp":654739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>In order to study the possible autoimmune basis of multiple sclerosis (MS) a quantitative method has been used to investigate breakdown of human myelin in vitro. We found that serum from MS patients and controls was generally devoid of any myelin degradative activity. However, isolated peripheral blood mononuclear cells from 43% of MS patients showed significant myelin degradative activity as did those from 61.5% of patients with rheumatoid arthritis (RA). Myelin degradation by cells was found in only 13% of patients with other neurological diseases and in no healthy controls. It is proposed that this non-specific peripheral cellular immune degradative activity originates from cells activated within the central nervous system of MS patients or the joints of individuals with RA. As a result, activity in the blood only indirectly reflects the ongoing inflammatory response at the primary site, accounting for the lack of correlation between changes in the blood and the clinical status of the MS patient. We further propose that the lack of in vitro myelin degradative activity in cells recovered from the cerebrospinal fluid is due to autoaggressive cells being sequestered to the brain.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb05408.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:29:15Z","timestamp":1280179755000},"page":"86-92","source":"Crossref","is-referenced-by-count":5,"title":["Degradation of human myelin <i>in vitro<\/i> by leucocytes from patients with multiple sclerosis"],"prefix":"10.1093","volume":"82","author":[{"given":"S J","family":"OWEN","sequence":"first","affiliation":[{"name":"Department of Neurochemistry, Institute of Neurology, London. England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"WATSON","sequence":"additional","affiliation":[{"name":"Department of Neurochemistry, Institute of Neurology, London. England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A N","family":"DAVISON","sequence":"additional","affiliation":[{"name":"Department of Neurochemistry, Institute of Neurology, London. England"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713204793100_b1","first-page":"248","article-title":"The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes","volume":"61","author":"Bellamy","year":"1985","journal-title":"Clin. exp. Immunol."},{"key":"2022011713204793100_b2","first-page":"341","article-title":"Multiple sclerosis: serum induced demyelination in tissue culture","volume-title":"International Symposium on the Aetiology and Pathogenesis of the Demyelinating Diseases","author":"Bornstein","year":"1976"},{"key":"2022011713204793100_b3","first-page":"43","article-title":"Serum demyelinating activity in multiple sclerosis","volume-title":"multiple Sclerosis Immunological, Diagnostic and Therapeutic Aspects (Current Problems in Neurology No. 3)","author":"Bradbury","year":"1987"},{"key":"2022011713204793100_b4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0022-510X(84)90092-3","article-title":"Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera","volume":"65","author":"Bradbury","year":"1984","journal-title":"J. neurol. Sci."},{"key":"2022011713204793100_b5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-510X(84)90080-7","article-title":"New approach to study of in vitro toxicity of multiple sclerosis and other sera","volume":"65","author":"Bradbury","year":"1984","journal-title":"J. neurol. Sci."},{"key":"2022011713204793100_b6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0022-510X(85)90085-1","article-title":"Comparison of in vitro demyelination and cytotoxicity of humoral factors in multiple sclerosis and other neurological diseases","volume":"70","author":"Bradbury","year":"1985","journal-title":"J. neurol. Sci."},{"key":"2022011713204793100_b7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-5728(88)90137-3","article-title":"Hypothesis: a role for tumour necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis","volume":"18","author":"Brosnan","year":"1988","journal-title":"J. Neuroimmunol."},{"key":"2022011713204793100_b8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","article-title":"Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2\u00a3,3\u00a3-cyclic nucleotide 3\u00a3-phosphodiesterase in the CNS of adult rats","volume":"52","author":"Brunner","year":"1989","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0167-5699(89)90235-1","article-title":"MS: a localised immune disease of the central nervous system","volume":"10","author":"Calder","year":"1989","journal-title":"Immunol. Today"},{"key":"2022011713204793100_b10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-5728(89)90007-6","article-title":"Absence of a correlation between T lymphocyte subsets and clinical activity in relapsing-remitting multiple sclerosis","volume":"22","author":"Capra","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"2022011713204793100_b11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1212\/WNL.30.7.749","article-title":"Multiple sclerosis: serum gamma globulin and demyelination in organ culture","volume":"30","author":"Grundke-Iqbal","year":"1980","journal-title":"Neurology"},{"key":"2022011713204793100_b12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410220121","article-title":"In vivo labelling of blood Tcells in rapid traffic into cerebrospinal fluid in multiple sclerosis","volume":"22","author":"Hafler","year":"1987","journal-title":"Ann. Neurol."},{"key":"2022011713204793100_b13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.1989.tb07363.x","article-title":"Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination","volume":"53","author":"Kerlero de Rosbo","year":"1989","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1471-4159.1970.tb02252.x","article-title":"2\u00a3,3\u00a3-cyclic nucleotide 3\u00a3-phosphohydrolase in brains of mutant mice with deficient myelination","volume":"17","author":"Kurihara","year":"1970","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/oxfordjournals.bmb.a071393","article-title":"Diagnosis and classification of multiple sclerosis","volume":"33","author":"McDonald","year":"1977","journal-title":"Br. med. Bull."},{"key":"2022011713204793100_b16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.159.1.77","article-title":"Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges and brain during acute viral meningoencephalitis","volume":"159","author":"Moench","year":"1984","journal-title":"J. exp. Med."},{"key":"2022011713204793100_b17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM198009253031301","article-title":"Detection of in vivo stimulated cerebrospinal fluid lymphocytes by flow cytometry in patients with multiple sclerosis","volume":"303","author":"Noronha","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"2022011713204793100_b18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1471-4159.1973.tb07519.x","article-title":"Myelination in rat brain: method of myelin isolation","volume":"21","author":"Norton","year":"1973","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00691806","article-title":"Lymphatic efflux of intracerebrally injected cells","volume":"45","author":"Oehmichen","year":"1979","journal-title":"Acta neuropathol."},{"key":"2022011713204793100_b20","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.38.11.1739","article-title":"Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI","volume":"38","author":"Oger","year":"1988","journal-title":"Neurology"},{"key":"2022011713204793100_b21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/brain\/110.6.1579","article-title":"The role of NMR imaging in the assessment of MS and isolated neurological lesions","volume":"110","author":"Ormerod","year":"1987","journal-title":"Brain"},{"key":"2022011713204793100_b22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(88)92457-9","article-title":"Multiple sclerosis: a T-cell disease","volume":"ii","author":"Owen","year":"1988","journal-title":"Lancet"},{"key":"2022011713204793100_b23","first-page":"409","article-title":"Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis","volume":"38","author":"Prineas","year":"1978","journal-title":"Lab. Invest."},{"key":"2022011713204793100_b24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0404.1985.tb03204.x","article-title":"Membrane bound 2\u00a3,3\u00a3-cyclic nucleotide 3\u00a3-phosphohydrolase activity of lymphocytes, granulocytes and erythrocytes in multiple sclerosis","volume":"71","author":"Rastogi","year":"1985","journal-title":"Acta neurol. Scand."},{"key":"2022011713204793100_b25","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1471-4159.1985.tb05462.x","article-title":"Correlation between 2\u00a3,3\u00a3-cyclic nucleotide phosphohydrolase activity and demyelination in vitro using a syngeneic system","volume":"44","author":"Roth","year":"1985","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jnnp.52.5.559","article-title":"Randomised double blind controlled trial of cyclosporin in multiple sclerosis","volume":"52","author":"Rudge","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychol."},{"key":"2022011713204793100_b27","first-page":"345","article-title":"Tissue culture studies of demyelinating disease: a critical review","volume-title":"Ann. Neurol","author":"Seil","year":"1977"},{"key":"2022011713204793100_b28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/jnnp.50.5.532","article-title":"T lymphocyte derived demyelinating activity in multiple sclerosis patients in relapse","volume":"50","author":"Selmaj","year":"1987","journal-title":"J. Neurol. Neurosurg. Psychol."},{"key":"2022011713204793100_b29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410150610","article-title":"Tissue culture demyelination by normal human serum","volume":"15","author":"Silberberg","year":"1984","journal-title":"Ann. Neurol."},{"key":"2022011713204793100_b30","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1471-4159.1984.tb12706.x","article-title":"Isolation of membrane attack complex of complement from myelin membranes treated with serum complement","volume":"42","author":"Silverman","year":"1984","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b31","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.1976.tb02612.x","article-title":"2\u00a3,3\u00a3-cyclic NADP as a substrate for 2\u00a3,3\u00a3-cyclic nucleotide 3\u00a3-phosphohydrolase","volume":"27","author":"Sogin","year":"1976","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b32","first-page":"581","article-title":"IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases","volume":"67","author":"Tournier-Lasserve","year":"1987","journal-title":"Clin. exp. Immunol."},{"key":"2022011713204793100_b33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00314713","article-title":"MS: demyelination and myelination inhibition of organotypic tissue cultures of the spinal cord by sera of patients with multiple sclerosis and other neurological disease","volume":"218","author":"Ulrich","year":"1978","journal-title":"J. Neurol."},{"key":"2022011713204793100_b34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.1988.tb03032.x","article-title":"An in vitro micromethod for the quantitative assessment of central demyelination","volume":"50","author":"Watson","year":"1988","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1471-4159.1980.tb06294.x","article-title":"A sensitive fluorometric assay for 2\u00a3,3\u00a3-cyclic nucleotide 3\u00a3-phosphohydrolase","volume":"35","author":"Weissbarth","year":"1980","journal-title":"J. Neurochem."},{"key":"2022011713204793100_b36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0166-2236(86)90077-9","article-title":"Cellular immune reactivity within the CNS","volume":"9","author":"Wekerle","year":"1986","journal-title":"Trends Neurosci."}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb05408.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/82\/1\/86\/42217401\/j.1365-2249.1990.tb05408.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/82\/1\/86\/42217401\/j.1365-2249.1990.tb05408.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T13:21:56Z","timestamp":1642425716000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/82\/1\/86\/6488679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05408.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1990,10]]},"published":{"date-parts":[[1990,10]]}}}